Skip to content

CareDx CDNA Preferred Stock, Shares Outstanding

Preferred Stock, Shares Outstanding at other companies

GeneDx Holdings logo
GeneDx HoldingsWGS
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Veracyte logo
VeracyteVCYT
Guardant Health logo
Guardant HealthGH
Agilent Technologies logo
Agilent TechnologiesA
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's preferred stock, shares outstanding.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's preferred stock, shares outstanding?
CareDx (CDNA) reported preferred stock, shares outstanding of $0 in Q1 2026.